{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T05:24:31Z","timestamp":1649136271847},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurosci Behav Physiol"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1007\/s11055-007-0160-y","type":"journal-article","created":{"date-parts":[[2007,8,15]],"date-time":"2007-08-15T13:36:18Z","timestamp":1187184978000},"page":"129-131","source":"Crossref","is-referenced-by-count":6,"title":["Antibodies to acetylcholine receptors in patients with different clinical forms of myasthenia and Lambert-Eaton myasthenic syndrome"],"prefix":"10.1007","volume":"37","author":[{"given":"D. V.","family":"Sidnev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Yu.","family":"Karganov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. I.","family":"Shcherbakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. B.","family":"Alchinova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. G.","family":"Sanadze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"Supplement1","key":"160_CR1","first-page":"19","volume":"8","author":"A. G. Sanadze","year":"2003","unstructured":"A. G. Sanadze, B. M. Gekht, D. V. Sidnev, et al., \u201cAntibodies to acetylcholine receptors in the diagnosis of myasthenia and other forms associated with pathology of neuromuscular transmission,\u201d Nevrol. Zh., 8, Supplement 1, 19\u201321 (2003).","journal-title":"Nevrol. Zh."},{"issue":"Supplement1","key":"160_CR2","first-page":"21","volume":"8","author":"D. V. Sidnev","year":"2003","unstructured":"D. V. Sidnev, A. G. Sanadze, T. V. Davydova, et al., \u201cAntibodies to muscles (antititin antibodies in the diagnosis of myasthenia associated with thymoma,\u201d Nevrol. Zh., 8, Supplement 1, 21\u201323 (2003).","journal-title":"Nevrol. Zh."},{"key":"160_CR3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1749-6632.1998.tb10971.x","volume":"841","author":"J. Aarli","year":"1998","unstructured":"J. Aarli, G. Skeie, A. Mygland, and N. Gilhus, \u201cMuscle striation antibodies in myasthenia gravis. Diagnostic and functional significance,\u201d Ann. N.Y. Acad. Sci., 841, 505\u2013515 (1998).","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"160_CR4","unstructured":"R. J. Barohn, \u201cHow to administer the quantitative myasthenia test,\u201d Myasthenia Gravis Foundation of America, Inc. (1966)."},{"key":"160_CR5","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1749-6632.1998.tb11015.x","volume":"841","author":"R. J. Barohn","year":"1998","unstructured":"R. J. Barohn, D. McIntire, L. Herbelin, et al., \u201cReliability testing of the quantitative myasthenia gravis score,\u201d Ann. N.Y. Acad. Sci., 841, 769\u2013772 (1998).","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"160_CR6","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1056\/NEJM198209233071301","volume":"307","author":"D. B. Drachman","year":"1982","unstructured":"D. B. Drachman, R. N. Adams, L. F. Josifek, and S. G. Self, \u201cFunctional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis,\u201d New Engl. J. Med., 307, 769\u2013773 (1982).","journal-title":"New Engl. J. Med."},{"key":"160_CR7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1749-6632.1993.tb22927.x","volume":"681","author":"A. Engel","year":"1993","unstructured":"A. Engel, \u201cThe investigation of congenital myasthenic syndromes,\u201d Ann. N.Y. Acad. Sci., 681, 425\u2013435 (1993).","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"160_CR8","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/(SICI)1097-4598(199707)20:7<800::AID-MUS3>3.0.CO;2-B","volume":"20","author":"C. Gotti","year":"1997","unstructured":"C. Gotti, B. Balestra, R. Mantegazza, et al., \u201cDetection of antibody sub-populations in myasthenia gravis using a non-radioactive new enzyme immunoassay,\u201d Muscle & Nerve, 20, 800\u2013808 (1997).","journal-title":"Muscle & Nerve"},{"key":"160_CR9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1006\/clin.1995.1042","volume":"74","author":"P. F. Kennel","year":"1995","unstructured":"P. F. Kennel, J. T. Cilquin, S. Braun, et al., \u201cMyasthenia gravis: comparative autoantibody assays using human muscle, TE671-and glucocorticoid-treated TE671 cells as sources of antigen,\u201d Clin. Immunopathol., 74, 293\u2013296 (1995).","journal-title":"Clin. Immunopathol."},{"key":"160_CR10","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1749-6632.1993.tb22917.x","volume":"681","author":"B. Lang","year":"1994","unstructured":"B. Lang, J. Newsom-Davis, C. Prior, and D. Wray, \u201cAntibody specificities in Lambert-Eaton myasthenic syndrome,\u201d Ann. N.Y. Acad. Sci., 681, 382\u2013393 (1994).","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"160_CR11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF00194096","volume":"17","author":"B. Lang","year":"1995","unstructured":"B. Lang and J. Newsom-Davis, \u201cImmunopathology of the Lambert-Eaton myasthenic syndrome,\u201d in: Springer Seminars in Immunopathology, 17, 3\u201315 (1995).","journal-title":"Springer Seminars in Immunopathology"},{"key":"160_CR12","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1056\/NEJM199506013322203","volume":"332","author":"V. A. Lennon","year":"1995","unstructured":"V. A. Lennon, Th. J. Kyrzer, G. E. Griesmann, et al., \u201cCalcium channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes,\u201d New Engl. J. Med., 332, 1467\u20131474 (1995).","journal-title":"New Engl. J. Med."},{"key":"160_CR13","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1172\/JCI17429","volume":"111","author":"V. A. Lennon","year":"2003","unstructured":"V. A. Lennon, L. G. Ermilov, J. H. Szurszewski, and S. Vernino, \u201cImmunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease,\u201d J. Clin. Invest., 111, 907\u2013913 (2003).","journal-title":"J. Clin. Invest."},{"key":"160_CR14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0065-2776(08)60847-0","volume":"42","author":"J. Lindstrom","year":"1988","unstructured":"J. Lindstrom, D. Shelton, and Y. Fujii, \u201cMyasthenia gravis,\u201d Adv. Immunol., 42, 233\u2013284 (1988).","journal-title":"Adv. Immunol."},{"key":"160_CR15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF02740634","volume":"2","author":"J. Lindstrom","year":"1997","unstructured":"J. Lindstrom, \u201cNicotinic acetylcholine receptors in health and disease,\u201d Molecular Neurobiology, 2, 193\u2013222 (1997).","journal-title":"Molecular Neurobiology"},{"key":"160_CR16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/jnnp.58.1.85","volume":"58","author":"M. Motomura","year":"1995","unstructured":"M. Motomura, I. Johnston, B. Lang, et al., \u201cAn improved diagnostic assay for Lambert-Eaton myasthenic syndrome,\u201d J. Neurol. Neurosurg. Psychiat., 58, 85\u201387 (1995).","journal-title":"J. Neurol. Neurosurg. Psychiat."},{"issue":"5","key":"160_CR17","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.clinph.2004.12.013","volume":"116","author":"S. J. Oh","year":"2005","unstructured":"S. J. Oh and E. Sher, \u201cMG and LEMS overlap syndrome: case report with electrophysiological and immunological evidence,\u201d Clin. Neurophysiol., 116, No. 5, 1167\u20131171 (2005).","journal-title":"Clin. Neurophysiol."},{"key":"160_CR18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/brain\/111.3.577","volume":"111","author":"J. O\u2019Neill","year":"1988","unstructured":"J. O\u2019Neill, N. Murray, and J. Newsom-Davis, \u201cThe Lambert-Eaton myasthenic syndrome. A review of 50-cases,\u201d Brain, 111, 577\u2013596 (1988).","journal-title":"Brain"},{"key":"160_CR19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1749-6632.1987.tb51286.x","volume":"505","author":"A. Vincent","year":"1987","unstructured":"A. Vincent, P. J. Whiting, M. Schluep, et al., \u201cAntibody heterogeneity and specificity in myasthenia gravis,\u201d Ann. N.Y. Acad. Sci., 505, 106\u2013120 (1987).","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"160_CR20","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1158\/1078-0432.CCR-04-0735","volume":"10","author":"S. Vernino","year":"2004","unstructured":"S. Vernino and V. A. Lennon, \u201cAutoantibody profiles and neurological correlations of thymoma,\u201d Clin. Cancer Res., 10, 7270\u20137275 (2004).","journal-title":"Clin. Cancer Res."},{"key":"160_CR21","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1212\/WNL.41.11.1836","volume":"41","author":"R. Voltz","year":"1991","unstructured":"R. Voltz, R. Hohlfield, A. Faten-Mothadam, et al., \u201cMyasthenia gravis: measurement of anti-AChR autoantibodies using cell line TE671,\u201d Neurology, 41, 1836\u20131838 (1991).","journal-title":"Neurology"},{"key":"160_CR22","first-page":"447","volume":"127","author":"N. Willcox","year":"1987","unstructured":"N. Willcox, M. Schluep, M. A. Ritter, et al., \u201cMyasthenic and nonmyasthenic thymoma: an expansion of a minor cortical epithelial cell subset?\u201d Amer. J. Pathol., 127, 447\u2013460 (1987).","journal-title":"Amer. J. Pathol."},{"key":"160_CR23","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/0952-7915(93)90105-2","volume":"5","author":"N. Willcox","year":"1993","unstructured":"N. Willcox, \u201cMyasthenia gravis,\u201d Curr. Opin. Immunol., 5, 910\u2013917 (1993).","journal-title":"Curr. Opin. Immunol."}],"container-title":["Neuroscience and Behavioral Physiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11055-007-0160-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11055-007-0160-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11055-007-0160-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T04:01:12Z","timestamp":1559361672000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11055-007-0160-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["160"],"URL":"https:\/\/doi.org\/10.1007\/s11055-007-0160-y","relation":{},"ISSN":["0097-0549","1573-899X"],"issn-type":[{"value":"0097-0549","type":"print"},{"value":"1573-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}